ADHD-Focused Cingulate Prices Public Offering, Shares Detailed Pivotal Trial Data

Cingulate Inc CING shares are trading lower after the company priced its $4-million public offering at around 58 cents per share and accompanying warrants. The offering includes 6.93 million shares and Series A and Series B warrants to purchase up to 6.93 million and up to 3.46 million shares,…#cingulateinccing #seriesaandseriesb #kansascity #kansas #ctx1301 #treatmenteffectsize #cingulate

Source: Reuters: Health - September 11, 2023 Category: Consumer Health News Source Type: news